New treatment options for lennox-gastaut syndrome

Current Treatment Options in Neurology

Volumn 15, Issue 4, 2013, Pages 519-528

  Lemmon, Monica E ^a   Kossoff, Eric H ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Clobazam; Corpus callostomy; Epilepsy; Felbamate; Ketogenic diet; Lamotrigine; Lennox Gastaut syndrome; Levetiracetam; LGS; Rufinamide; Topiramate; Treatment; Vagus nerve stimulator; Valproic acid; Zonisamide

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CARBONATE DEHYDRATASE INHIBITOR; CLOBAZAM; CLONAZEPAM; CLOPIDOGREL; ETIRACETAM; FELBAMATE; LAMOTRIGINE; OPIATE; ORAL CONTRACEPTIVE AGENT; PHENOBARBITAL; PHENYTOIN; PLACEBO; RALFINAMIDE; TOPIRAMATE; VALPROIC ACID; WARFARIN; ZONISAMIDE;

ABDOMINAL PAIN; ACIDOSIS; ANEMIA; ANHIDROSIS; APLASTIC ANEMIA; ARTICLE; ASEPTIC MENINGITIS; ATONIC SEIZURE; BLURRED VISION; BRAIN SURGERY; CLOSED ANGLE GLAUCOMA; COGNITIVE DEFECT; CONFUSION; CONSTIPATION; CORPUS CALLOSOTOMY; COUGHING; DEPRESSION; DIARRHEA; DIPLOPIA; DIZZINESS; DRUG ANTAGONISM; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG ERUPTION; DRUG FEVER; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG POTENTIATION; DRUG TOLERANCE; FATIGUE; GROWTH DISORDER; HAIR LOSS; HEART PALPITATION; HEMIPARESIS; HOARSENESS; HUMAN; HYPERAMMONEMIA; HYPERLIPIDEMIA; HYPERSALIVATION; HYPERTHERMIA; HYPERTRANSAMINASEMIA; HYPOGLYCEMIA; IRRITABILITY; KETOGENIC DIET; LENNOX GASTAUT SYNDROME; LETHARGY; LEUKOPENIA; LIVER FAILURE; MAINTENANCE DRUG DOSE; MAXIMUM PLASMA CONCENTRATION; METABOLIC ACIDOSIS; MYOPIA; NAUSEA; NEPHROLITHIASIS; NEUTROPENIA; PANCREATITIS; PARESTHESIA; PHOTOSENSITIVITY; PSYCHOSIS; RESPIRATION DEPRESSION; SHORT QT INTERVAL; SIDE EFFECT; SLEEP DISORDERED BREATHING; SOMNOLENCE; SORE THROAT; SPEECH DISORDER; STEVENS JOHNSON SYNDROME; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE; SURGICAL INFECTION; TERATOGENICITY; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS; TREMOR; UPPER RESPIRATORY TRACT INFECTION; VAGUS NERVE STIMULATION; VOICE CHANGE; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 84882246524     PISSN: 10928480     EISSN: 15343138     Source Type: Journal    
DOI: 10.1007/s11940-013-0223-z     Document Type: Article

References (40)

1. Gibbs F, Davis H, Lennox W. Electroencephalogram in epilepsy and in conditions of impaired consciousness. Arch Neurol Psychiatry. 1935;34:1133.
2. Lennox W. The petit mal epilepsies: their treatment with tridione. JAMA. 1945;129:1069-74.
3. Lennox WG, Davis JP. Clinical correlates of the fast and slow spike wave electroencephalogram. Pediatrics. 1950;5:626-44.
4. Gastaut H, Roger J, Soulayrol R, et al. Childhood epileptic encephalopathy with diffuse slow spike-waves (otherwise known as "petit mal variant") or Lennox syndrome. Epilepsia. 1966;7:139-79.
5. Commission on classification and terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989;30:389-99.
6. Arzimanoglou A, French J, Blume WT, et al. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol. 2009;8:82-93. This consensus paper provides a useful, current summary of the approach to diagnosing and managing LGS from experts in the field.
7. Crumrine P. Management of seizures in Lennox-Gastaut syndrome. Paediatr Drugs. 2011;13:107-18.
8. Hancock EC, Cross HH. Treatment of Lennox-Gastaut syndrome. Cochrane Database Syst Rev. 2009;8:CD003277. This Cochrane Review summarizes and evaluates pharmacologic treatment studies in LGS.
9. Giarratano M, Standley K, Benbadis SR. Clobazam for treatment of epilepsy. Expert Opin Pharmacother. 2012;13(2):227-33.
10. Ng YT, Conry JA, Drummond R, et al. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome. Neurology. 2011;77:1473. This class II study showed that clobazam was efficacious in reducing drop attacks in LGS.
11. Motte J, Trevathan E, Arvidsson JF, et al. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. N Engl J Med. 1997;337(25):1807-12.
12. Chhun S, Troude P, Villeneuve N, et al. A prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: continuous spikes and waves during sleep is definitely a target. Seizure. 2011;20(4):320-5.
13. De Los Reyes EC, Sharp GB, Williams JP, et al. Levetiracetam in the treatment of Lennox-Gastaut syndrome. Pediatr Neurol. 2004;30:254-6.
14. Major P, Greenberg E, Khan A, et al. Pyridoxine supplementation for the treatment of levetiracetam-induced behavior side effects in children: preliminary results. Epilepsy Behav. 2008;13:557-9.
15. Wheless JW, Vazquez B. Rufinamide: a novel broad-spectrum antiepileptic drug. Epilepsy Curr. 2010;10(1):1-6.
16. Glauser T, Kluger G, Sachdeo R, et al. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology. 2008;70:1950-8.
17. Lyseng-Williamson KA, Yang LP. Topiramate: a review of its use in the treatment of epilepsy. Drugs. 2007;67:2231-56.
18. Sachdeo RC, Glauser TA, Ritter F, et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group. Neurology. 1999;52(9):1882-7.
19. Glauser TA, Pellock JM. Zonisamide in pediatric epilepsy: review of the Japanese experience. J Child Neurol. 2002;17(2):87-96.
20. You S, Kang H, Kim H, et al. Clinical efficacy of zonisamide in Lennox-Gastaut syndrome: Korean multicentric experience. Brain Dev. 2008;30:287-90.
21. Kelemen A, Rásonyl G, Neuwirth M, et al. Our clinical experience with zonisamide in resistant generalized epilepsy syndromes. Ideggyogy Sz. 2011;64:187-92.
22. Wheless JW, Clarke DF, Carpenter D. Treatment of pediatric epilepsy: expert opinion, 2005. J Child Neurol. 2005;20(Suppl1):S1e56.
23. The Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of Felbamate in childhood epileptic encephalopathy (Lennox-Gastaut Syndrome). N Engl J Med. 1993;328:29-33.
24. Pellock JM, Faught E, Leppik IE, et al. Felbamate: consensus of current clinical experience. Epilepsy Res. 2006;71:89-101.
25. Vassella F, Rüdeberg A, Da Silva V, et al. Double-blind study on the anti-convulsive effect of phenobarbital and valproate in the Lennox syndrome. Schweiz Med Wochenschr. 1978;108(19):713-6.
26. Burton BS. On the propyl derivatives and decomposition products of ethylacetoacetate. Am Chem J. 1882;3:385-95.
27. Löscher W. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs. 2002;16(10):669-94.
28. Freeman JM, Vining EP, Kossoff EH, et al. A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia. 2009;50(2):322-5.
29. Lemmon ME, Terao NN, Ng YT, et al. Efficacy of the ketogenic diet in Lennox-Gastaut syndrome: a retrospective review of one institution's experience and summary of the literature. Dev Med Child Neurol. 2012;54:464-8.
30. Kossoff EH, McGrogan JR, Bluml RM, et al. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia. 2006;47:421-4.
31. Kossoff EH, Dorward JL. The modified Atkins diet. Epilepsia. 2008;8:37-41.
32. McNally MA, Pyzik PL, Rubenstein JE, et al. Empiric use of potassium citrate reduces kidney-stone incidence with the ketogenic diet. Pediatrics. 2009;124:300-4.
33. Rougier A, Claverie B, Pedespan JM, et al. Callosotomy for intractable epilepsy: overall outcome. J Neurosurg Sci. 1997;41:51-7.
34. Maehara T, Shimizu H. Surgical outcome of corpus callosotomy in patients with drop attacks. Epilepsia. 2001;42:67-71.
35. Gupta A, Chirla A, Wyllie E, et al. Pediatric epilepsy surgery in focal lesions and generalized electroencephalogram abnormalities. Pediatr Neurol. 2007;37:8-15.
36. Wyllie E, Lachhwani DK, Gupta A, et al. Successful surgery for epilepsy due to early brain lesions despite generalized EEG findings. Neurology. 2007;69:389-97.
37. Fisher RS. Therapeutic devices for epilepsy. Ann Neurol. 2012;71(2):157-68.
38. Frost M, Gates J, Helmers SL, et al. Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome. Epilepsia. 2001;42:1148-52.
39. You SJ, Kang HC, Ko TS, et al. Comparison of corpus callosotomy and vagus nerve stimulation in children with Lennox-Gastaut syndrome. Brain Dev. 2008;30:195-9.
40. Cersósimo RO, Bartuluchi M, Fortini S, et al. Vagus nerve stimulation: effectiveness and tolerability in 64 pediatric patients with refractory epilepsies. Epileptic Disord. 2011;13:382-8.